Evidence map›Paper›PMID 34502473›Full record

ArticleInternational journal of molecular sciences2021

Antibacterial and Cellular Behaviors of Novel Zinc-Doped Hydroxyapatite/Graphene Nanocomposite for Bone Tissue Engineering.

H Maleki-Ghaleh, M H Siadati, A Fallah, B Koc, M Kavanlouei, P Khademi-Azandehi, E Moradpur-Tari, Y Omidi, J Barar, Y Beygi-Khosrowshahi and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

H Maleki-GhalehResearch Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz 51664-14766, Iran.ORCID 0000-0003-2020-6025
M H SiadatiFaculty of Materials Science and Engineering, K. N. Toosi University of Technology, Tehran 19919-43344, Iran.ORCID 0000-0003-2347-1246
A FallahFaculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Turkey.ORCID 0000-0002-7744-4246
B KocFaculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Turkey.
M KavanloueiMaterials Engineering Department, Faculty of Engineering, Urmia University, Urmia 57561-51818, Iran.ORCID 0000-0002-2385-6798
P Khademi-AzandehiResearch Center for Advanced Materials, Faculty of Materials Engineering, Sahand University of Technology, Tabriz 51335-1996, Iran.
E Moradpur-TariMaterials Engineering Department, Faculty of Engineering, Tarbiat Modares University, Tehran 14115-111, Iran.ORCID 0000-0003-0027-2519
Y OmidiDepartment of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33314, USA.
J BararResearch Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz 51664-14766, Iran.
Y Beygi-KhosrowshahiDepartment of Chemical Engineering, Faculty of Engineering, Azarbaijan Shahid Madani University, Tabriz 53751-71379, Iran.ORCID 0000-0002-0102-4229
Alan P KumarDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0002-3754-5712
K AdibkiaResearch Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz 51664-14766, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria are one of the significant causes of infection in the body after scaffold implantation. Effective use of nanotechnology to overcome this problem is an exciting and practical solution. Nanoparticles can cause bacterial degradation by the electrostatic interaction with receptors and cell walls. Simultaneously, the incorporation of antibacterial materials such as zinc and graphene in nanoparticles can further enhance bacterial degradation. In the present study, zinc-doped hydroxyapatite/graphene was synthesized and characterized as a nanocomposite material possessing both antibacterial and bioactive properties for bone tissue engineering. After synthesizing the zinc-doped hydroxyapatite nanoparticles using a mechanochemical process, they were composited with reduced graphene oxide. The nanoparticles and nanocomposite samples were extensively investigated by transmission electron microscopy, X-ray diffraction, and Raman spectroscopy. Their antibacterial behaviors against Escherichia coli and Staphylococcus aureus were studied. The antibacterial properties of hydroxyapatite nanoparticles were found to be improved more than 2.7 and 3.4 times after zinc doping and further compositing with graphene, respectively. In vitro cell assessment was investigated by a cell viability test and alkaline phosphatase activity using mesenchymal stem cells, and the results showed that hydroxyapatite nanoparticles in the culture medium, in addition to non-toxicity, led to enhanced proliferation of bone marrow stem cells. Furthermore, zinc doping in combination with graphene significantly increased alkaline phosphatase activity and proliferation of mesenchymal stem cells. The antibacterial activity along with cell biocompatibility/bioactivity of zinc-doped hydroxyapatite/graphene nanocomposite are the highly desirable and suitable biological properties for bone tissue engineering successfully achieved in this work.

Indexed as

Anti-Bacterial AgentsTissue EngineeringAnimalsBone and BonesBone Marrow CellsDurapatiteEscherichia coliGraphiteMiceNanocompositesStaphylococcus aureusStem CellsZincAnti-Bacterial AgentsDurapatiteGraphiteZincantibacterialbiocompatibilitygraphenehydroxyapatitenanocompositezinc

Identifiers

PMID34502473
PMCPMC8431478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.